Thailand approves COVID-19 AstraZeneca vaccine for emergency use

Bangkok (NNT) – The FDA Secretary General Paisal Dunkhum, said today the FDA had approved the registration of the COVID-19 vaccine produced by AstraZeneca in Italy.

The company nearly 10,000 pages of documents for registration in Thailand for approved use during the state of emergency since December 22, 2020. Efficacy, quality and safety of the vaccine was considered by the FDA.

He added that the first delivery of vaccine from AstraZeneca is due in February, consisting of 50,000 doses. The import license lasts one year.

RelatedArticles

Medical Tourism: can China compete with Thailand?

November 28, 2024

Steady Growth Expected in Singapore’s Medical Device Market Amid Aging Population

November 2, 2024

Market Opportunities in Indonesia for Indian Investors

October 25, 2024

Global pharma firms to increase investments in mainland China

October 15, 2024

When the vaccine arrives in Thailand, the Department of Medical Sciences will conduct a random inspection of the vaccine to determine its quality before providing it to people. More deliveries, numbering 150,000 doses of vaccine in total, will follow in March and April, he said.

As for the production of the COVID-19 vaccine by AstraZeneca and Siam Bioscience, he said registration of a production facility in Thailand will allow it to become effective in Thailand in May.

50,000 COVID-19 vaccine doses to arrive next month

(NNT) – The first lot of 50,000 doses of COVID-19 vaccine developed by AstraZeneca will arrive in Thailand early next month, after receiving approval from the country’s Food and Drug Administration (FDA). Previously, the doses were set to arrive in May. They will first be given to medical personnel.

Deputy Prime Minister and Public Health Minister, Anutin Charnvirakul, chaired a meeting today (Jan 25) to discuss COVID-19 vaccine management. The meeting was attended by the ministry’s executives and five working bodies. The ministry previously set up subcommittees to take on various aspects.

Today, the meeting followed up on vaccine management and distribution, after the FDA recently approved the emergency use of the vaccine developed by AstraZeneca and produced abroad.

Initially, the recipients of the vaccine are required to install the Mor Prom application, to monitor side effects of the vaccine. The Public Health Minister said there may be side effects, but the possibility is very low. He urged the people not to be too worried because there are officials specifically assigned to take care of them.

The government will provide full support to ensure that the vaccine distribution covers all Thai citizens in a timely manner and without any disparity.

After receiving the first lot of COVID-19 vaccine doses on February 1, more doses will arrive in March and April, including the vaccine developed in China.